We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
SARS‐CoV‐2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone.
- Authors
Ahmed, S.M.A.; Volontè, M.; Isoletta, E.; Vassallo, C.; Tomasini, C.F.; Lilleri, D.; Zelini, P.; Musella, V.; Klersy, C.; Brazzelli, V.
- Abstract
SARS-CoV-2 serology in patients on biological therapy or apremilast for psoriasis: a study of 93 patients in the Italian red zone Finally, we used the serological data to determine the usefulness of an over-the-phone questionnaire for SARS-CoV-2 positivity performed by Brazzelli I et al i .3 on the same cohort of psoriatic patients. None of the 12 positive patients had a severe infection or required hospitalisation due to SARS-CoV-2 infection.
- Subjects
BIOTHERAPY; APREMILAST; SARS-CoV-2; PSORIATIC arthritis; SEROLOGY; DERMATOLOGISTS
- Publication
Journal of the European Academy of Dermatology & Venereology, 2022, Vol 36, Issue 2, pe86
- ISSN
0926-9959
- Publication type
Article
- DOI
10.1111/jdv.17721